Flossbach Von Storch AG trimmed its holdings in Danaher Co. (NYSE:DHR) by 0.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 6,764,501 shares of the conglomerate’s stock after selling 12,420 shares during the period. Danaher accounts for approximately 6.0% of Flossbach Von Storch AG’s portfolio, making the stock its 4th largest position. Flossbach Von Storch AG’s holdings in Danaher were worth $627,881,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Danaher by 1.3% during the second quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after purchasing an additional 520,776 shares in the last quarter. BlackRock Inc. raised its holdings in Danaher by 3.2% during the second quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after purchasing an additional 1,233,876 shares in the last quarter. FMR LLC raised its holdings in Danaher by 0.9% during the second quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after purchasing an additional 183,183 shares in the last quarter. Parnassus Investments CA raised its holdings in Danaher by 0.3% during the third quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after purchasing an additional 29,381 shares in the last quarter. Finally, Dodge & Cox raised its holdings in Danaher by 3.0% during the second quarter. Dodge & Cox now owns 5,250,773 shares of the conglomerate’s stock worth $443,113,000 after purchasing an additional 151,550 shares in the last quarter. 76.19% of the stock is owned by institutional investors and hedge funds.

DHR has been the subject of several analyst reports. Robert W. Baird reissued a “buy” rating and set a $99.00 price target on shares of Danaher in a report on Friday, December 15th. Citigroup increased their price target on shares of Danaher to $107.00 and gave the stock a “buy” rating in a report on Friday, December 15th. Cowen reissued a “buy” rating and set a $110.00 price target on shares of Danaher in a report on Tuesday, January 30th. UBS Group assumed coverage on shares of Danaher in a research report on Monday, January 22nd. They set a “buy” rating and a $99.97 target price on the stock. Finally, Stifel Nicolaus restated a “buy” rating and set a $110.00 target price on shares of Danaher in a research report on Friday, January 19th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher presently has an average rating of “Buy” and an average price target of $100.13.

In other news, EVP William K. Daniel sold 131,066 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the sale, the executive vice president now directly owns 270,523 shares in the company, valued at $27,606,872.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Insiders sold 274,913 shares of company stock worth $27,729,293 over the last quarter. Company insiders own 12.20% of the company’s stock.

Shares of Danaher Co. (DHR) opened at $94.46 on Friday. The company has a market cap of $65,710.00, a P/E ratio of 26.99, a PEG ratio of 1.99 and a beta of 1.04. Danaher Co. has a 1 year low of $78.97 and a 1 year high of $104.82. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. The business had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The company’s quarterly revenue was up 10.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.05 earnings per share. sell-side analysts predict that Danaher Co. will post 4.37 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were given a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. Danaher’s dividend payout ratio is presently 16.00%.

TRADEMARK VIOLATION NOTICE: This article was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://theolympiareport.com/2018/02/11/danaher-co-dhr-shares-sold-by-flossbach-von-storch-ag.html.

Danaher Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.